Try our beta test site
111 studies found for:    "Sclerosis" AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Recruiting EPID Multiple Sclerosis Pregnancy Study
Condition: Multiple Sclerosis
Interventions: Drug: Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG;   Drug: Extavia (interferon beta-1b), Novartis Pharma AG;   Drug: Rebif (interferon beta-1a), Merck Serono Europe Ltd;   Drug: Plegridy (peginterferon beta-1a), Biogen Idec Ltd;   Drug: Avonex (interferon beta-1a), Biogen Idec Ltd;   Drug: MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046);   Other: No MSDMDs therapy (control)
22 Unknown  POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: nomegestrol acetate;   Drug: estradiol;   Drug: placebo
23 Completed Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon-1beta (Betaseron, BAY86-5046)
24 Completed
Has Results
A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: abatacept;   Drug: Placebo
25 Completed The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention:
26 Unknown  Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo
27 Active, not recruiting Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: ibudilast;   Drug: Placebo
28 Recruiting Biogen Multiple Sclerosis Pregnancy Exposure Registry
Conditions: Multiple Sclerosis;   Exposure During Pregnancy
Interventions: Drug: dimethyl fumarate;   Drug: Peginterferon beta-1a;   Drug: Dalclizumab High Yield Process
29 Completed Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
30 Recruiting Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: Amyotrophic Lateral Sclerosis
31 Enrolling by invitation Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells
Condition: Multiple Sclerosis
Intervention: Procedure: Hematopoietic stem cell transplantation
32 Unknown  Effects of Spinal Cord Injury on Female Sexual Response
Conditions: Female Sexual Dysfunction;   Multiple Sclerosis;   Spinal Cord Injury
Intervention: Procedure: Sympathetic manipulation on sexual arousal in women
33 Unknown  Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Cistanche Total Glycosides
34 Completed G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Granulocyte Colony Stimulating Factor;   Drug: NS
35 Recruiting Pregnancy Registry Trial
Condition: Multiple Sclerosis
Intervention: Drug: Fingolimod
36 Completed Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
37 Terminated Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients
Conditions: Healthy Volunteers;   Multiple Sclerosis
Interventions: Drug: 2B3-201;   Drug: Placebo;   Drug: Methylprednisolone hemisuccinate
38 Recruiting Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)
Condition: Multiple Sclerosis, Secondary Progressive
Intervention: Drug: Domperidone
39 Completed Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study
Condition: Multiple Sclerosis
Intervention: Biological: glutamate and aspartate
40 Completed Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
Conditions: Lymphangioleiomyomas;   Tuberous Sclerosis;   Lymphangioleiomyomatosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.